神経リハビリテーション機器市場：製品別、治療領域別-2025-2030年の世界予測

神経リハビリテーション機器市場の2023年の市場規模は13億2,000万米ドルで、2024年には14億2,000万米ドルに達すると予測され、CAGR 7.62％で成長し、2030年には22億2,000万米ドルに達すると予測されています。

神経リハビリテーション機器市場には、神経機能の回復、強化、維持を支援するために設計された技術や機器が含まれます。この範囲には、脳卒中、外傷性脳損傷、パーキンソン病などの神経疾患からの回復を支援することを目的とした、ロボット工学、ブレイン・コンピュータ・インターフェイス、非侵襲性脳刺激装置、ウェアラブル機器などが含まれます。神経疾患の増加、人口の高齢化、革新的な治療アプローチに対する意識の高まりにより、神経リハビリテーションの必要性が高まっています。この機器は、病院、診療所、家庭のさまざまな環境で使用され、さまざまな神経障害レベルの患者に治療とモニタリングを提供しています。ヘルスケア主、患者、保険会社までもが主要なエンドユーザーであり、これらの機器を活用して、移動、言語、運動技能のリハビリテーションの成果を向上させています。

この市場に影響を与える主な成長要因には、AIやIoT統合などの技術的進歩、ヘルスケア支出の増加、神経学研究に対する政府の支援イニシアティブなどがあります。潜在的なビジネスチャンスは、高度な医療ソリューションへの需要が高まっている新興市場や、遠隔モニタリングや治療ソリューションを可能にする遠隔医療統合にあります。このような機会を捉えるための推奨事項としては、未開拓の地域をターゲットにすること、手頃な価格でありながら先進的な機器を開発すること、ヘルスケアプロバイダーと戦略的パートナーシップを結んで市場参入を強化することなどが挙げられます。

しかし、この市場は、高額な機器コスト、長い承認プロセス、これらの技術を効果的に運用するためのより良い訓練を受けた専門家の必要性などの限界に直面しています。これらの課題は、厳しい規制環境や効果的な展開に必要な技術的成熟度によってさらに深刻化しています。

技術革新の機が熟した分野には、AIを活用した個別化リハビリテーション・プログラム、機械学習ベースの診断、より使いやすく利用しやすい機器の開発などがあります。調査努力は、患者の利用範囲を拡大するために、デバイスの携帯性を高め、コストを削減することに向けられる可能性があります。神経リハビリテーション機器市場はダイナミックであり、急速な技術進歩と患者中心のケア重視の高まりを特徴とし、成長とイノベーションの大きな可能性を提供します。

市場力学：急速に進化する神経リハビリテーション機器市場の主要市場インサイトを公開

神経リハビリテーション機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 脳損傷や脳卒中などの神経疾患の発生率の増加
  • 患者やヘルスケアプロバイダーの意識の高まり
  • 世界の老人人口の増加
• 市場抑制要因
  • 比較的高額なリハビリテーションサービス
• 市場機会
  • 電気刺激における新技術の開発と研究開発活動
  • デジタル化の浸透に伴うウェアラブルデバイスの出現
• 市場の課題
  • 患者数に比べてリハビリセンターの数が不足しています。

ポーターのファイブフォース：神経リハビリテーション機器市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経リハビリテーション機器市場における外部からの影響の把握

外部マクロ環境要因は、神経リハビリテーション機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経リハビリテーション機器市場における競合情勢の把握

神経リハビリテーション機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経リハビリテーション機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経リハビリテーション機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経リハビリテーション機器市場における成功への道筋を描く

神経リハビリテーション機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 脳損傷や脳卒中などの神経疾患の発生率の増加
    • 患者とヘルスケア従事者の間で高まる意識
    • 世界的に高齢化が進む
  • 抑制要因
    • 比較的高価なリハビリテーションサービス
  • 機会
    • 研究開発活動と連携した電気刺激に関する新技術の開発
    • デジタル化の浸透によりウェアラブルデバイスが普及
  • 課題
    • 患者数に比べてリハビリセンターの数が不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 神経リハビリテーション機器市場：製品別

• 脳コンピュータインターフェース
• ニューロロボティクス
• 非侵襲性刺激装置
• ウェアラブルデバイス

第7章 神経リハビリテーション機器市場治療領域別

• 脳と脊髄の損傷
• 脳性麻痺
• 多発性硬化症
• パーキンソン病
• 脳卒中

第8章 南北アメリカの神経リハビリテーション機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の神経リハビリテーション機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの神経リハビリテーション機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AlterG, Inc.
• Biometrics Ltd.
• Bioness Inc. by Bioventus Inc.
• Bionik Laboratories Corp.
• BioXtreme Ltd.
• Ekso Bionics Holdings, Inc.
• Eodyne Systems, SL
• Hocoma AG by DIH Medical
• Kinestica d.o.o.
• MediTouch Ltd.
• Medtronic PLC
• Neofect
• Neuro Rehab VR
• Reha Technology AG
• Rehab-Robotics Company Limited

LIST OF FIGURES

• FIGURE 1. NEUROREHABILITATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROREHABILITATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. NEUROREHABILITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. NEUROREHABILITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROREHABILITATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROREHABILITATION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY BRAIN-COMPUTER INTERFACE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROROBOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY NONINVASIVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY BRAIN & SPINAL CORD INJURY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 25. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 26. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 37. CHINA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 38. CHINA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 39. INDIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 40. INDIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 74. ITALY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 75. ITALY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 82. POLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 83. POLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 84. QATAR NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 85. QATAR NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 104. NEUROREHABILITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. NEUROREHABILITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Neurorehabilitation Devices Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.42 billion in 2024, and is projected to grow at a CAGR of 7.62%, to USD 2.22 billion by 2030.

The neurorehabilitation devices market encompasses technology and equipment designed to aid in the recovery, enhancement, and maintenance of neurological function. This scope includes robotics, brain-computer interfaces, non-invasive brain stimulators, and wearable devices aimed at assisting patients in recovery from neurological conditions like stroke, traumatic brain injuries, and Parkinson's disease. The necessity for neurorehabilitation is rising due to increasing incidences of neurological disorders, an aging population, and greater awareness of innovative treatment approaches. This equipment is applied across hospitals, clinics, and home settings, providing therapy and monitoring for patients with varied neurological impairment levels. Healthcare providers, patients, and even insurance companies are primary end-users, leveraging these devices for improved outcomes in mobility, speech, and motor skill rehabilitation.

Key growth factors influencing this market include technological advancements, such as AI and IoT integration, increasing healthcare expenditure, and supportive government initiatives for neurological research. Potential opportunities lie in emerging markets, where demand is growing for advanced medical solutions, and telemedicine integration, allowing remote monitoring and therapy solutions. Recommendations to seize these opportunities include targeting unpenetrated geographic regions, developing affordable yet advanced devices, and forming strategic partnerships with healthcare providers to enhance market reach.

However, the market faces limitations, such as high device costs, lengthy approval processes, and the need for better-trained professionals to administer these technologies effectively. These challenges are compounded by stringent regulatory environments and the technological maturity required for effective deployment.

Areas ripe for innovation include AI-driven personalized rehabilitation programs, machine learning-based diagnostics, and the development of more user-friendly and accessible devices. Research efforts could be directed towards enhancing device portability and reducing costs to expand patient reach. The neurorehabilitation devices market is dynamic, characterized by rapid technological advancements and an increasing emphasis on patient-centered care, offering significant potential for growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurorehabilitation Devices Market

The Neurorehabilitation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of neurological disorders such as brain injuries and stroke
  • Growing awareness among patients and healthcare providers
  • Rising geriatric population globally
• Market Restraints
  • Relatively expensive rehabilitation services
• Market Opportunities
  • Development of new technologies in electrostimulation coupled with research and development activities
  • Emerging availability of wearable devices with penetration of digitization
• Market Challenges
  • Lack of adequate number of rehabilitation centers compared to the number of patients

Porter's Five Forces: A Strategic Tool for Navigating the Neurorehabilitation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurorehabilitation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurorehabilitation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurorehabilitation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurorehabilitation Devices Market

A detailed market share analysis in the Neurorehabilitation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurorehabilitation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurorehabilitation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurorehabilitation Devices Market

A strategic analysis of the Neurorehabilitation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurorehabilitation Devices Market, highlighting leading vendors and their innovative profiles. These include AlterG, Inc., Biometrics Ltd., Bioness Inc. by Bioventus Inc., Bionik Laboratories Corp., BioXtreme Ltd., Ekso Bionics Holdings, Inc., Eodyne Systems, SL, Hocoma AG by DIH Medical, Kinestica d.o.o., MediTouch Ltd., Medtronic PLC, Neofect, Neuro Rehab VR, Reha Technology AG, and Rehab-Robotics Company Limited.

Market Segmentation & Coverage

This research report categorizes the Neurorehabilitation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Products, market is studied across Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators, and Wearable Devices.
• Based on Therapy Area, market is studied across Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Parkinson's Disease, and Stroke.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of neurological disorders such as brain injuries and stroke
    • 5.1.1.2. Growing awareness among patients and healthcare providers
    • 5.1.1.3. Rising geriatric population globally
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively expensive rehabilitation services
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of new technologies in electrostimulation coupled with research and development activities
    • 5.1.3.2. Emerging availability of wearable devices with penetration of digitization
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of adequate number of rehabilitation centers compared to the number of patients
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurorehabilitation Devices Market, by Products

• 6.1. Introduction
• 6.2. Brain-Computer Interface
• 6.3. Neurorobotics
• 6.4. Noninvasive Stimulators
• 6.5. Wearable Devices

7. Neurorehabilitation Devices Market, by Therapy Area

• 7.1. Introduction
• 7.2. Brain & Spinal Cord Injury
• 7.3. Cerebral Palsy
• 7.4. Multiple Sclerosis
• 7.5. Parkinson's Disease
• 7.6. Stroke

8. Americas Neurorehabilitation Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Neurorehabilitation Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Neurorehabilitation Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AlterG, Inc.
• 2. Biometrics Ltd.
• 3. Bioness Inc. by Bioventus Inc.
• 4. Bionik Laboratories Corp.
• 5. BioXtreme Ltd.
• 6. Ekso Bionics Holdings, Inc.
• 7. Eodyne Systems, SL
• 8. Hocoma AG by DIH Medical
• 9. Kinestica d.o.o.
• 10. MediTouch Ltd.
• 11. Medtronic PLC
• 12. Neofect
• 13. Neuro Rehab VR
• 14. Reha Technology AG
• 15. Rehab-Robotics Company Limited